tiprankstipranks
Trending News
More News >
Rekah Pharmaceutical Industry Ltd. (IL:REKA)
:REKA
Israel Market
Advertisement

Rekah (REKA) Ratios

Compare
0 Followers

Rekah Ratios

IL:REKA's free cash flow for Q2 2025 was 0.23. For the 2025 fiscal year, IL:REKA's free cash flow was decreased by and operating cash flow was -0.02. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.57 1.75 1.75 2.25 2.10
Quick Ratio
0.89 1.08 1.09 1.34 1.20
Cash Ratio
0.02 0.13 0.15 0.19 0.34
Solvency Ratio
0.07 0.05 0.09 0.11 0.12
Operating Cash Flow Ratio
0.07 0.20 0.28 0.21 0.10
Short-Term Operating Cash Flow Coverage
0.35 0.94 1.99 1.12 0.42
Net Current Asset Value
-50.21M -77.81M -43.20M -42.37M -26.75M
Leverage Ratios
Debt-to-Assets Ratio
0.32 0.37 0.34 0.38 0.40
Debt-to-Equity Ratio
0.86 1.15 0.95 0.96 1.00
Debt-to-Capital Ratio
0.46 0.53 0.49 0.49 0.50
Long-Term Debt-to-Capital Ratio
0.30 0.49 0.36 0.37 0.35
Financial Leverage Ratio
2.72 3.12 2.77 2.53 2.54
Debt Service Coverage Ratio
0.72 0.86 1.50 1.43 1.11
Interest Coverage Ratio
-0.85 0.00 2.35 2.51 3.60
Debt to Market Cap
0.69 1.07 0.63 0.45 0.39
Interest Debt Per Share
12.54 15.79 14.11 15.02 15.08
Net Debt to EBITDA
5.41 6.13 3.33 4.07 3.26
Profitability Margins
Gross Profit Margin
22.94%24.93%26.92%24.69%25.86%
EBIT Margin
-2.46%0.00%2.05%5.06%7.52%
EBITDA Margin
7.77%8.09%13.76%13.72%14.95%
Operating Profit Margin
-1.83%0.90%4.53%5.36%7.88%
Pretax Profit Margin
-4.22%-2.19%0.12%2.92%5.33%
Net Profit Margin
-4.31%-2.15%-0.70%2.51%4.07%
Continuous Operations Profit Margin
-4.31%-2.15%-0.70%2.51%4.07%
Net Income Per EBT
102.09%98.01%-572.27%85.91%76.27%
EBT Per EBIT
230.40%-242.60%2.69%54.51%67.66%
Return on Assets (ROA)
-3.19%-1.43%-0.46%1.52%2.57%
Return on Equity (ROE)
-8.39%-4.44%-1.26%3.83%6.52%
Return on Capital Employed (ROCE)
-2.01%0.85%4.28%4.18%6.72%
Return on Invested Capital (ROIC)
-1.83%0.80%-22.67%3.35%4.65%
Return on Tangible Assets
-3.69%-1.65%-0.50%1.64%2.60%
Earnings Yield
-10.13%-4.13%-1.16%2.49%3.53%
Efficiency Ratios
Receivables Turnover
2.80 2.73 0.00 0.00 0.00
Payables Turnover
2.94 3.06 2.43 3.24 3.08
Inventory Turnover
2.55 2.50 2.32 2.22 2.01
Fixed Asset Turnover
2.33 2.08 1.79 1.49 1.46
Asset Turnover
0.74 0.66 0.65 0.60 0.63
Working Capital Turnover Ratio
4.03 3.04 2.57 2.18 2.50
Cash Conversion Cycle
148.91 160.30 6.98 51.98 63.13
Days of Sales Outstanding
130.24 133.54 0.00 0.00 0.00
Days of Inventory Outstanding
143.01 146.03 157.48 164.54 181.45
Days of Payables Outstanding
124.34 119.26 150.51 112.55 118.31
Operating Cycle
273.25 279.56 157.48 164.54 181.45
Cash Flow Ratios
Operating Cash Flow Per Share
0.83 2.50 3.44 1.85 0.99
Free Cash Flow Per Share
0.14 1.49 2.78 0.63 -0.66
CapEx Per Share
0.70 1.01 0.66 1.23 1.65
Free Cash Flow to Operating Cash Flow
0.16 0.59 0.81 0.34 -0.67
Dividend Paid and CapEx Coverage Ratio
1.20 2.47 2.23 1.51 0.60
Capital Expenditure Coverage Ratio
1.20 2.47 5.21 1.51 0.60
Operating Cash Flow Coverage Ratio
0.07 0.16 0.25 0.13 0.07
Operating Cash Flow to Sales Ratio
0.03 0.09 0.13 0.08 0.04
Free Cash Flow Yield
1.14%10.07%17.85%2.70%-2.47%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-9.87 -24.23 -86.42 40.12 28.33
Price-to-Sales (P/S) Ratio
0.43 0.52 0.60 1.01 1.15
Price-to-Book (P/B) Ratio
0.85 1.08 1.09 1.54 1.85
Price-to-Free Cash Flow (P/FCF) Ratio
88.09 9.93 5.60 37.04 -40.51
Price-to-Operating Cash Flow Ratio
14.18 5.91 4.53 12.55 27.11
Price-to-Earnings Growth (PEG) Ratio
0.02 -0.10 0.66 -1.03 0.10
Price-to-Fair Value
0.85 1.08 1.09 1.54 1.85
Enterprise Value Multiple
10.96 12.56 7.72 11.41 10.97
Enterprise Value
266.13M 327.02M 310.71M 412.95M 435.36M
EV to EBITDA
10.96 12.56 7.72 11.41 10.97
EV to Sales
0.85 1.02 1.06 1.56 1.64
EV to Free Cash Flow
174.05 19.39 9.86 57.55 -57.65
EV to Operating Cash Flow
28.42 11.53 7.97 19.51 38.59
Tangible Book Value Per Share
8.66 7.84 9.79 12.27 14.14
Shareholders’ Equity Per Share
13.82 13.73 14.29 15.16 14.50
Tax and Other Ratios
Effective Tax Rate
-0.02 -0.02 6.72 0.14 0.24
Revenue Per Share
27.76 28.40 25.79 23.12 23.26
Net Income Per Share
-1.20 -0.61 -0.18 0.58 0.95
Tax Burden
1.02 0.98 -5.72 0.86 0.76
Interest Burden
1.71 0.00 0.06 0.58 0.71
Research & Development to Revenue
0.01 0.01 0.01 <0.01 <0.01
SG&A to Revenue
0.03 0.10 0.03 0.02 0.02
Stock-Based Compensation to Revenue
>-0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
-0.70 -4.10 -19.09 3.20 1.05
Currency in ILS
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis